RevealAI-Lung

JSON twin: https://www.healthaidb.com/software/revealai-lung.json

Company Name

RevealDx

Product URL

https://reveal-dx.com

Company URL

https://reveal-dx.com

Categories

• diagnostic Support
• clinical Decision Support
• radiology
• oncology Care
• ai Clinical Documentation Integrity
• Diagnostic
• Oncology
• Ai-driven Software

Summary

RevealAI-Lung is an AI-driven software developed by RevealDx to assist radiologists in assessing lung nodules, aiming to improve early detection of malignant nodules and reduce false positives.

Description

RevealAI-Lung is a computer-aided diagnostic (CADx) software that analyzes lung CT scans to compute a Malignancy Similarity Index (mSI) for detected nodules. This index aids clinicians in making informed decisions, potentially leading to fewer unnecessary procedures and quicker diagnoses. The software integrates seamlessly with existing PACS systems, providing rapid analysis with a single click. It has been validated in clinical studies, demonstrating significant improvements in early cancer detection and a reduction in false positives. As of November 2022, RevealDx anticipated FDA clearance for RevealAI-Lung in early 2023. The software is CE-marked and has been evaluated in clinical settings, including the Royal United Hospitals Bath NHS Foundation Trust, where it showed positive results in assessing high-risk patients. RevealDx has partnered with Sirona Medical to integrate RevealAI-Lung into Sirona's unified radiology platform, Workspace, enhancing radiologists' workflow by embedding AI into clinical processes. Additionally, RevealDx has appointed Contextflow as its exclusive distributor in the European Union and selected territories, aiming to improve lung cancer screening through enhanced nodule characterization. The company has also partnered with Riverain Technologies to integrate their technologies, further enhancing lung cancer detection capabilities. RevealDx is a Seattle-based software company focused on improving lung cancer outcomes through advanced AI-enabled decision-support software. The company's primary product, RevealAI-Lung, is a CE-marked algorithm designed to enhance the efficiency and accuracy of lung nodule assessment. This technology aims to address limitations in lung cancer screening programs, particularly inefficient nodule detection methods and suboptimal specificity for lung cancer detection. RevealAI-Lung uses a malignancy Similarity Index (mSI) to inform clinical decision-making, potentially resulting in fewer unnecessary procedures and quicker diagnoses. Clinical studies have shown that RevealAI-Lung can achieve a 29% reduction in false positives and a 45% increase in early diagnosis. As of November 2022, RevealDx was anticipating FDA clearance for RevealAI-Lung in early 2023. The company has formed significant partnerships with organizations like Sirona Medical, Contextflow, and Riverain Technologies to enhance the capabilities and distribution of RevealAI-Lung, aiming to improve lung cancer detection and screening processes globally.

Api Available

unknown

Certifications

• CE mark
• Health Canada medical device license

Company Founding

2014

Company Offices

• United States

Compliance

• CE mark
• Health Canada medical device license

Customers

Data Residency

US/EU regions

Data Standards

• DICOM

Deployment Model

• on_prem
• cloud

Features

• Malignancy Similarity Index (mSI) computation
• Single-click nodule analysis from PACS
• 3D lesion radiomic analysis
• Broader lung and chest contextual analysis
• Ensemble classification with radiomic features
• Similarity display of comparable nodules
• Fast results displayed within seconds
• Integration of mSI into radiology reports
• Cost-savings by aiding nodule management decisions

Id

SW0754

Integration Partners

Integrations

• contextflow (SEARCH Lung CT)
• Sirona Medical
• Volpara Health
• Softneta / medDream (PACS vendor integrations)
• Riverain Technologies

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

Os Platforms

• Windows
• Linux

Pricing Details

contact vendor

Pricing Model

subscription

Privacy Features

• BAA available
• consent management
• anonymization
• data minimization

Product Code

SW0754

Product Name

RevealAI-Lung

Ratings

Regions Available

• United States
• European Union
• Canada
• Australia
• New Zealand

Related Urls

• https://healthairegister.com/radiology/products/revealdx-revealai-lung

Release Year

""

Security Features

• encryption
• audit logs

Specialties

• Pulmonology
• Oncology
• Radiology

Support Channels

System Requirements

DICOM-compatible PACS; typical PACS/server environment

Target Users

• radiologists
• clinicians
• healthcare providers

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "RevealAI-Lung",
  "company_name": "RevealDx",
  "product_url": "https://reveal-dx.com",
  "company_url": "https://reveal-dx.com",
  "related_urls": [
    "https://healthairegister.com/radiology/products/revealdx-revealai-lung"
  ],
  "product_code": "SW0754",
  "summary": "RevealAI-Lung is an AI-driven software developed by RevealDx to assist radiologists in assessing lung nodules, aiming to improve early detection of malignant nodules and reduce false positives.",
  "description": "RevealAI-Lung is a computer-aided diagnostic (CADx) software that analyzes lung CT scans to compute a Malignancy Similarity Index (mSI) for detected nodules. This index aids clinicians in making informed decisions, potentially leading to fewer unnecessary procedures and quicker diagnoses. The software integrates seamlessly with existing PACS systems, providing rapid analysis with a single click. It has been validated in clinical studies, demonstrating significant improvements in early cancer detection and a reduction in false positives. As of November 2022, RevealDx anticipated FDA clearance for RevealAI-Lung in early 2023. The software is CE-marked and has been evaluated in clinical settings, including the Royal United Hospitals Bath NHS Foundation Trust, where it showed positive results in assessing high-risk patients. RevealDx has partnered with Sirona Medical to integrate RevealAI-Lung into Sirona's unified radiology platform, Workspace, enhancing radiologists' workflow by embedding AI into clinical processes. Additionally, RevealDx has appointed Contextflow as its exclusive distributor in the European Union and selected territories, aiming to improve lung cancer screening through enhanced nodule characterization. The company has also partnered with Riverain Technologies to integrate their technologies, further enhancing lung cancer detection capabilities. RevealDx is a Seattle-based software company focused on improving lung cancer outcomes through advanced AI-enabled decision-support software. The company's primary product, RevealAI-Lung, is a CE-marked algorithm designed to enhance the efficiency and accuracy of lung nodule assessment. This technology aims to address limitations in lung cancer screening programs, particularly inefficient nodule detection methods and suboptimal specificity for lung cancer detection. RevealAI-Lung uses a malignancy Similarity Index (mSI) to inform clinical decision-making, potentially resulting in fewer unnecessary procedures and quicker diagnoses. Clinical studies have shown that RevealAI-Lung can achieve a 29% reduction in false positives and a 45% increase in early diagnosis. As of November 2022, RevealDx was anticipating FDA clearance for RevealAI-Lung in early 2023. The company has formed significant partnerships with organizations like Sirona Medical, Contextflow, and Riverain Technologies to enhance the capabilities and distribution of RevealAI-Lung, aiming to improve lung cancer detection and screening processes globally.",
  "categories": [
    "diagnostic Support",
    "clinical Decision Support",
    "radiology",
    "oncology Care",
    "ai Clinical Documentation Integrity",
    "Diagnostic",
    "Clinical Decision Support",
    "Radiology",
    "Oncology",
    "Ai-driven Software"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "radiologists",
    "clinicians",
    "healthcare providers"
  ],
  "specialties": [
    "Pulmonology",
    "Oncology",
    "Radiology"
  ],
  "regions_available": [
    "United States",
    "European Union",
    "Canada",
    "Australia",
    "New Zealand"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "subscription",
  "pricing_details": "contact vendor",
  "license": "commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "2014",
  "deployment_model": [
    "on_prem",
    "cloud"
  ],
  "os_platforms": [
    "Windows",
    "Linux"
  ],
  "features": [
    "Malignancy Similarity Index (mSI) computation",
    "Single-click nodule analysis from PACS",
    "3D lesion radiomic analysis",
    "Broader lung and chest contextual analysis",
    "Ensemble classification with radiomic features",
    "Similarity display of comparable nodules",
    "Fast results displayed within seconds",
    "Integration of mSI into radiology reports",
    "Cost-savings by aiding nodule management decisions"
  ],
  "optional_modules": [],
  "integrations": [
    "contextflow (SEARCH Lung CT)",
    "Sirona Medical",
    "Volpara Health",
    "Softneta / medDream (PACS vendor integrations)",
    "Riverain Technologies"
  ],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "DICOM-compatible PACS; typical PACS/server environment",
  "compliance": [
    "CE mark",
    "Health Canada medical device license"
  ],
  "certifications": [
    "CE mark",
    "Health Canada medical device license"
  ],
  "security_features": [
    "encryption",
    "audit logs"
  ],
  "privacy_features": [
    "BAA available",
    "consent management",
    "anonymization",
    "data minimization"
  ],
  "data_residency": "US/EU regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "\"\"",
  "integration_partners": [],
  "id": "SW0754",
  "slug": "revealai-lung",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/revealai-lung.json"
  }
}